Singapore researchers produce new antibody to combat flu, pneumonia | Vaccine News Daily

Researchers from Nanyang Technological University (NTU) in Singapore have created and developed an antibody that has been shown to boost survival chances for patients suffering from the flu and pneumonia, Cell Reports said on Feb. 10.

The antibody has shown to be effective in lab tests and is now being designed for use in humans. NTU scientists are also using the new antibody to develop a diagnostic kit that can help physicians track the recovery progress of flu and pneumonia patients.

via Singapore researchers produce new antibody to combat flu, pneumonia | Vaccine News Daily.